![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Staskin David R.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.22, Iss.12, 2005-01, pp. : 1013-1028
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trospium Chloride in the Management of Overactive Bladder
Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vulnerable Elderly Patients and Overactive Bladder Syndrome
Drugs & Aging, Vol. 27, Iss. 9, 2010-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fesoterodine: a guide to its use in overactive bladder syndrome
Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pediatric Overactive Bladder Syndrome: Pathophysiology and Management
Pediatric Drugs, Vol. 9, Iss. 6, 2007-01 ,pp. :